Zobrazeno 1 - 3
of 3
pro vyhledávání: '"I. Martín Sobrino"'
Autor:
P. Gómez Ramírez, I. Martín Sobrino, M. Nieto Palomares, A. García Maruenda, A. Sánchez Gómez, M. El Harmochi Daoud, A. Herrera Ortega, M. Usero Ruiz
Publikováno v:
Neurology Perspectives, Vol 4, Iss , Pp 230-231 (2024)
Externí odkaz:
https://doaj.org/article/d7f3b03664a746789ce118bdcd5ec7bc
Autor:
Alberto Carretero-González, G.A. De Velasco Oria de Rueda, I. Martín Sobrino, I. Sáez Sanz, D. Castellano Gauna
Publikováno v:
Annals of Oncology. 30:v40
Background Immune checkpoint inhibitors (ICIs) are beneficial in a subset of metastatic renal cell carcinoma (mRCC) patients. However, no biomarker has been shown to be useful to select which patient benefits and the role of programmed death-ligand 1
Autor:
Carretero-González A; Medical Oncology Department, University Hospital 12 de Octubre, 28041 Madrid, Spain., Lora D; Clinical Research Unit, IMAS12-CIBERESP, University Hospital 12 de Octubre, 28041 Madrid, Spain., Martín Sobrino I; School of Medicine, Universidad Complutense de Madrid, University Hospital 12 de Octubre, 28040 Madrid, Spain., Sáez Sanz I; School of Medicine, Universidad Complutense de Madrid, University Hospital 12 de Octubre, 28040 Madrid, Spain., Bourlon MT; Hemato-Oncology Department, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, 14080 Mexico City, Mexico., Anido Herranz U; Medical Oncology Department, University Clinical Hospital of Santiago de Compostela, 15076 Santiago de Compostela, Spain., Martínez Chanzá N; Medical Oncology Department, Jules Bordet Institute, Université Libre de Bruxelles, 1000 Brussels, Belgium., Castellano D; Medical Oncology Department, University Hospital 12 de Octubre, 28041 Madrid, Spain., de Velasco G; Medical Oncology Department, University Hospital 12 de Octubre, 28041 Madrid, Spain.
Publikováno v:
Cancers [Cancers (Basel)] 2020 Jul 17; Vol. 12 (7). Date of Electronic Publication: 2020 Jul 17.